Oct 25, 2026 11:52AM
Oct 23, 2026 09:26PM
Oct 23, 2026 04:38PM
Oct 23, 2026 04:37PM
Oct 22, 2026 06:00AM
Oct 21, 2026 06:07AM
Oct 21, 2026 06:05AM Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II / III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer
Oct 19, 2026 07:00AM
Oct 5, 2026 08:19AM
Oct 5, 2026 07:01AM
Oct 5, 2026 07:00AM
Oct 2, 2026 06:04AM
Oct 2, 2026 02:30AM
Sep 29, 2026 12:12PM High-Stakes October has these Biotechs Entering Crucial Stretch
Sep 28, 2026 05:33PM
Sep 28, 2026 05:30PM
Sep 22, 2026 06:01AM
Sep 22, 2026 06:00AM
Sep 15, 2026 06:01AM
Sep 15, 2026 06:00AM
Sep 13, 2026 07:47PM Ivonescimab cuts death risk 27% vs. pembrolizumab in lung cancer
Sep 13, 2026 07:00AM
Aug 25, 2026 06:39PM
Aug 25, 2026 06:00PM
Aug 25, 2026 07:02AM
Aug 25, 2026 07:00AM
Aug 12, 2026 09:22AM
Aug 12, 2026 09:22AM Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for First-Line Treatment of Patients with Squamous Non-Small Cell Lung Cancer
Aug 5, 2026 07:00AM
Jul 24, 2026 07:51AM
Jul 23, 2026 04:06PM
Jul 23, 2026 04:05PM
Jul 22, 2026 04:30PM
Jul 22, 2026 04:30PM
Jul 22, 2026 06:30AM Summit ivonescimab shows OS hazard ratio of 0.76 in lung cancer trial
Jul 22, 2026 06:30AM
Jul 16, 2026 08:00AM
Jul 14, 2026 07:00AM
Jul 14, 2026 07:00AM
Jun 9, 2026 04:47PM
Jun 9, 2026 04:47PM
Jun 4, 2026 04:30PM Summit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conference
Jun 1, 2026 02:53AM
May 31, 2026 09:06AM
May 30, 2026 08:00AM
May 14, 2026 09:15AM
May 4, 2026 07:32AM
Apr 30, 2026 04:32PM
Mar 27, 2026 08:16AM Summit Therapeutics to present ivonescimab data at ELCC 2026
Mar 27, 2026 08:15AM

335,219 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All